載入...
All-cause mortality of insulin plus dipeptidyl peptidase-4 inhibitors in persons with type 2 diabetes
BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitors could effectively reduce HbA(1C) and postprandial hyperglycemia and could incur only minimal danger of hypoglycemia. Patients with uncontrolled diabetes might be treated by the complementary action of insulin plus DPP-4 inhibitors. Here, we compa...
Na minha lista:
| 發表在: | BMC Endocr Disord |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6321656/ https://ncbi.nlm.nih.gov/pubmed/30611254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-018-0330-7 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|